Deal terms for the sale of Kerala Institute of Medical Sciences (KIMS), an Indian hospital group with a strong Middle Eastern presence, are starting to materialise. Some 8-10 large private equity funds want existing investors, Ascent Capital and OrbiMed Advisors’, 40% stake plus an extra 15-20% from new shares. That will cost around INR 2,050 crore (US$300m) and negotiations will start in a month’s time.